Azenta Inc (AZTA)
42.62
-1.88
(-4.24%)
USD |
NASDAQ |
Nov 14, 16:00
42.00
-0.62
(-1.47%)
After-Hours: 07:53
Azenta Free Cash Flow (Quarterly): -4.802M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -4.802M |
March 31, 2024 | 1.529M |
December 31, 2023 | 14.51M |
September 30, 2023 | 29.69M |
June 30, 2023 | 9.235M |
March 31, 2023 | -21.01M |
December 31, 2022 | -39.86M |
September 30, 2022 | -4.071M |
June 30, 2022 | -435.34M |
March 31, 2022 | -101.27M |
December 31, 2021 | -2.791M |
September 30, 2021 | 8.913M |
June 30, 2021 | 35.73M |
March 31, 2021 | 23.91M |
December 31, 2020 | 28.50M |
September 30, 2020 | 41.56M |
June 30, 2020 | 17.61M |
March 31, 2020 | -77.36M |
December 31, 2019 | 16.13M |
September 30, 2019 | 24.34M |
June 30, 2019 | 30.14M |
March 31, 2019 | 9.849M |
December 31, 2018 | 2.704M |
September 30, 2018 | 27.74M |
June 30, 2018 | 15.69M |
Date | Value |
---|---|
March 31, 2018 | 17.24M |
December 31, 2017 | 0.516M |
September 30, 2017 | 28.75M |
June 30, 2017 | 16.41M |
March 31, 2017 | 23.20M |
December 31, 2016 | 14.94M |
September 30, 2016 | 20.00M |
June 30, 2016 | 12.41M |
March 31, 2016 | 9.144M |
December 31, 2015 | -14.86M |
September 30, 2015 | 12.06M |
June 30, 2015 | 14.22M |
March 31, 2015 | -0.153M |
December 31, 2014 | 1.459M |
September 30, 2014 | 11.31M |
June 30, 2014 | 3.999M |
March 31, 2014 | 25.50M |
December 31, 2013 | 7.458M |
September 30, 2013 | 23.83M |
June 30, 2013 | 11.76M |
March 31, 2013 | 10.70M |
December 31, 2012 | 4.471M |
September 30, 2012 | 1.175M |
June 30, 2012 | 8.897M |
March 31, 2012 | 14.27M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-435.34M
Minimum
Jun 2022
41.56M
Maximum
Sep 2020
-24.17M
Average
8.913M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
Bruker Corp | 5.80M |
Harvard Bioscience Inc | -1.953M |
Bionano Genomics Inc | -21.06M |
Akoya Biosciences Inc | -11.21M |
Singular Genomics Systems Inc | -18.04M |